| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |